Toby Odenheim is the former Director of Technology and Governance at the Parker Institute for Cancer Immunotherapy (PICI). He is now Senior Vice President, Research & Development Technology at ProPharma Group.
Committed to accelerating the development of new medical treatments through effective technology adoption and continual process improvement.